MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/vaccines9111230

Медицинская библиотека · Vaccines · 2021

Chimeric Vaccines Based on Novel Insect-Specific Flaviviruses.

Harrison Jessica J, Hobson-Peters Jody, Bielefeldt-Ohmann Helle, Hall Roy A

СтатьяОбзорПеревод в очереди

Аннотация

Vector-borne flaviviruses are responsible for nearly half a billion human infections worldwide each year, resulting in millions of cases of debilitating and severe diseases and approximately 115,000 deaths. While approved vaccines are available for some of these viruses, the ongoing efficacy, safety and supply of these vaccines are still a significant problem. New technologies that address these issues and ideally allow for the safe and economical manufacture of vaccines in resource-poor countries where flavivirus vaccines are in most demand are urgently required. Preferably a new vaccine platform would be broadly applicable to all flavivirus diseases and provide new candidate vaccines for those diseases not yet covered, as well as the flexibility to rapidly pivot to respond to newly emerged flavivirus diseases. Here, we review studies conducted on novel chimeric vaccines derived from insect-specific flaviviruses that provide a potentially safe and simple system to produce highly effective vaccines against a broad spectrum of flavivirus diseases.

Для цитирования: Harrison Jessica J, Hobson-Peters Jody, Bielefeldt-Ohmann Helle, Hall Roy A. Chimeric Vaccines Based on Novel Insect-Specific Flaviviruses.. Vaccines. 2021. DOI: 10.3390/vaccines9111230.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.